de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78:1365–1372
Article PubMed PubMed Central Google Scholar
Macdonald RL, Schweizer TA (2017) Spontaneous subarachnoid haemorrhage. Lancet 389:655–666. https://doi.org/10.1016/S0140-6736(16)30668-7
Li MH, Chen SW, Li YD et al (2013) Prevalence of unruptured cerebral aneurysms in chinese adults aged 35 to 75 years: a cross-sectional study. Ann Intern Med 159:514–521. https://doi.org/10.7326/0003-4819-159-8-201310150-00004
Rinkel GJ, Djibuti M, Algra A, van Gijn J (1998) Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 29:251–256. https://doi.org/10.1161/01.str.29.1.251
Article CAS PubMed Google Scholar
Schievink WI, Torres VE, Piepgras DG, Wiebers DO (1992) Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:88–95
Article CAS PubMed Google Scholar
Nurmonen HJ, Huttunen T, Huttunen J et al (2017) Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population. Neurology 89:1852–1859. https://doi.org/10.1212/WNL.0000000000004597
Perrone RD, Malek AM, Watnick T (2015) Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 11:589–598. https://doi.org/10.1038/nrneph.2015.128
Article CAS PubMed PubMed Central Google Scholar
Räisänen S, Frösen J, Kurki M et al (2018) Impact of young age on the presentation of saccular intracranial aneurysms: population-based analysis of 4082 patients. Neurosurgery 82:815–823
Kim ST, Brinjikji W, Kallmes DF (2016) Prevalence of intracranial aneurysms in patients with connective tissue diseases: a retrospective study. Am J Neuroradiol 37:1422–1426
Article CAS PubMed PubMed Central Google Scholar
Rodrigues VJ, Elsayed S, Loeys BL, Dietz HC, Yousem DM (2009) Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. Am J Neuroradiol 30:1614–1619
Article CAS PubMed PubMed Central Google Scholar
Oderich G, Sullivan T, Bower T et al (2007) Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 46:475–484
Chihi M, Gembruch O, Darkwah Oppong M et al (2019) Intracranial aneurysms in patients with tuberous sclerosis complex: a systematic review. J Neurosurg Pediatr 24:174–183
Korja M, Silventoinen K, McCarron P et al (2010) Genetic epidemiology of spontaneous subarachnoid hemorrhage: Nordic twin study. Stroke 41:2458–2462. https://doi.org/10.1161/STROKEAHA.110.586420
Wills S, Ronkainen A, van der Voet M et al (2003) Familial intracranial aneurysms: an analysis of 346 multiplex finnish families. Stroke 34:1370–1374
Zhou S, Dion P, Rouleau G (2018) Genetics of intracranial aneurysms. Stroke 49:780–787
Kataoka H, Akagawa H, Ushio Y et al (2022) Mutation type and intracranial aneurysm formation in autosomal dominant polycystic kidney disease. Stroke Vasc Interv Neurol 2:e000203. https://doi.org/10.1161/SVIN.121.000203
Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635–642. https://doi.org/10.1016/S1474-4422(09)70126-7
Kataoka H, Nitta K, Hoshino J (2023) Visceral fat and attribute-based medicine in chronic kidney disease. Front Endocrinol. https://doi.org/10.3389/fendo.2023.1097596
Kataoka H, Mochizuki T, Ohara M et al (2022) Urate-lowering therapy for Ckd patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the feather study. Sci Rep 12:3784. https://doi.org/10.1038/s41598-022-07737-9
Article ADS CAS PubMed PubMed Central Google Scholar
Kataoka H, Ono K, Mochizuki T et al (2019) A body mass index-based cross-classification approach for the assessment of prognostic factors in chronic kidney disease progression. Kidney Blood Press Res 44:362–383. https://doi.org/10.1159/000501021
Article CAS PubMed Google Scholar
Kataoka H, Ohara M, Mochizuki T et al (2020) Sex differences in time-series changes in pseudo-R(2) values regarding hyperuricemia in relation to the kidney prognosis. J Pers Med. https://doi.org/10.3390/jpm10040248
Article PubMed PubMed Central Google Scholar
Sacristan JA (2015) Clinical research and medical care: towards effective and complete integration. BMC Med Res Methodol 15:4. https://doi.org/10.1186/1471-2288-15-4
Article PubMed PubMed Central Google Scholar
Butler WE, Barker FG II, Crowell RM (1996) Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery 38:506–515. https://doi.org/10.1097/00006123-199603000-00018
Article CAS PubMed Google Scholar
Horie S, Mochizuki T, Muto S et al (2016) Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol 20:493–509. https://doi.org/10.1007/s10157-015-1219-7
Article PubMed PubMed Central Google Scholar
Nishio S, Tsuchiya K, Nakatani S et al (2021) A digest from evidence-based clinical practice guideline for polycystic kidney disease 2020. Clin Exp Nephrol 25:1292–1302. https://doi.org/10.1007/s10157-021-02097-6
Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated Gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992. https://doi.org/10.1053/j.ajkd.2008.12.034
Article CAS PubMed Google Scholar
Kataoka H, Akagawa H, Yoshida R et al (2022) Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Sci Rep 12:18056–18056
Article ADS CAS PubMed PubMed Central Google Scholar
Curtis MJ, Bond RA, Spina D et al (2015) Experimental design and analysis and their reporting: new guidance for publication in Bjp. Br J Pharmacol 172:3461–3471. https://doi.org/10.1111/bph.12856
Article CAS PubMed PubMed Central Google Scholar
Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165:710–718. https://doi.org/10.1093/aje/kwk052
Mochizuki T, Tsuchiya K, Nitta K (2013) Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol 17:317–326. https://doi.org/10.1007/s10157-012-0741-0
Article CAS PubMed Google Scholar
Somlo S, Markowitz GS (2000) The pathogenesis of autosomal dominant polycystic kidney disease: an update. Curr Opin Nephrol Hypertens 9:385–394
Article CAS PubMed Google Scholar
Sato M, Kataoka H, Ushio Y et al (2020) High serum phosphate level as a risk factor to determine renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Medicines (Basel). https://doi.org/10.3390/medicines7030013
Kataoka H, Watanabe S, Sato M et al (2021) Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease. Hep Intl 15:791–803
Ushio Y, Kataoka H, Sato M et al (2020) Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Clin Exp Nephrol 24:500–508. https://doi.org/10.1007/s10157-020-01856-1
Article CAS PubMed Google Scholar
Kataoka H, Shimada Y, Nishio S et al (2023) Public support for patients with intractable diseases in japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol 27:809–811
Article CAS PubMed Google Scholar
Higashihara E, Nutahara K, Kojima M et al (1998) Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 80:421–427
Comments (0)